Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance) [Gastrointestinal Cancer]
Conclusion
Acute oxaliplatin-induced neuropathy symptoms do not always completely resolve between treatment cycles and are only half as severe on the first cycle as compared with subsequent cycles. There is a correlation between the severities of acute and chronic neuropathies.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Pachman, Qin, Seisler, Smith, Beutler, Ta, Lafky, Wagner-Johnston, Ruddy, Dakhil, Staff, Grothey, Loprinzi Tags: Supportive Care, Chemotherapy Gastrointestinal Cancer Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Chronic Pain | Eloxatin | Gastroenterology | Neurology | Pain | Peripheral Neuropathy | Study